Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — Q1 FY25 Earnings Presentation
23 slides from Amrutanjan Health Care's earnings presentation, Aug 13, 2024
Slide 1: Exchange cover letter for investor presentation
AHCL/ SE/25 /2024-25 August 14, 2024 The National Stock Exchange of IndiaLimited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1st Floor, Mumbai 400 051 P.J. Towers, Dalal Street, Mumbai 400 001 Symbol: AMRUTANJAN Scrip Code: 590006 Dear
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation Quarter Ended 30th June 2024 Date: 13th August 2024
Slide 3: Contents
Contents a. Business Update 1. Segment Performance 2. Activities 3. Operations b. Financials 1. Q1 FY25 Performance c. Management Commentary Investor Presentation | Quarter Ended 30 June 2024 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter Ended 30 June 2024 3
Slide 5: Segment Performance: OTC
Segment Performance: OTC Head Category Body Category Congestion Category • The Head category is valued at 1757 crores during MAT • The Body category in MAT June ’24* is valued at • Our congestion category, post-packaging refresh, June 24* period with a value growth of 10.0%* and a 3270 crores, showi
Slide 6: Segment Performance: Women's Hygiene and Beverages
Segment Performance: Women’s Hygiene and Beverages Women’s Hygiene Category Beverages Category • After reaching the milestone of 100 crores during last financial year, Comfy • Electro+, our rehydration brand, achieved a growth of 18% In Q1 FY continued its growth momentum in Q1 FY 24-25 as well. The
Slide 7: New Launches
New Launches Head Derma Care Women’s Hygiene • As a consumer centric company, AHCL is committed to • AHCL expanded into derma care space by launching Stop • In order to meet the growing consumer demand for meet the specific need for a headache relief product, Itch Anti-Fungal Powder spray, India’s f
Slide 8: TV and Digital Media (Beverages)
TV and Digital Media (Beverages) • AHCL continued with the Electro+ TV campaign with the new brand ambassador, Ruturaj Gaikwad, in Q1 FY 24-25 as well. • To capitalize on Ruturaj’s association, AHCL took IPL for the first time for Electro+ with the objective of driving awareness and consideration TV
Slide 9: Sampling and Visibility: OTC
Sampling and Visibility: OTC Sampling : Body Sampling : Derma Care Visibility: Head • One of AHCL’s key strategies to continuously • With Stop Itch being an unique format which needs • To create awareness for Amrutanjan Pain Cream engage with the consumers is through sampling so education among the
Slide 10: Sampling and Visibility: Women's Hygiene
Sampling and Visibility: Women’s Hygiene Sampling : Comfy and Period Pain Roll On Visibility : Comfy Slim Fit • School sampling activity was continued in Q1 ‘FY 24-25 in the states of Tamil • To increase the visibility and awareness for Comfy Slim Fit, AHCL Nadu, Jharkhand, Uttar Pradesh and Madhya
Slide 11: Sampling and Visibility: Beverages
Sampling and Visibility: Beverages Sampling : Electro+ Visibility: Electro+ • Sampling has always been the core to our trial generation activities and AHCL • AHCL’s partnership with Ruturaj Gaikwad was leveraged in the visibility activity did product sampling in Q1 FY 24-25 as well. Electro+ was sam
Slide 12: Operations Update – Sales and Distribution
Operations Update – Sales and Distribution Distribution Sales Effective Outlets Coverage (Avg. Monthly) Manpower 15% increase in Q1 FY ‘25 Decreased by 1% vs Q1 FY ‘24 Outlets Coverage (Annual) Productive Calls Increased by 8% Increased by 15% Closing Stock Reduced from 59 to 48 Manpower Productivit
Slide 13: Operations Update – IT
Operations Update – IT IT Projects SAP WOA Store SAP Bank Integration (ICICI E-billing systems & CCTV - Payments) completed, installed in Delhi, SAP Fiorri Mobile Apps Ahmedabad & Chennai rolled our for SAP users Additional Security Controls IT Trainings Completed Vulnerability & IT Security Policy
Slide 14: Operations Update – HR
Operations Update – HR HR Initiatives Coffee with MD Employee engagement activity which was designed to foster open communication, employees interaction, share ideas and gain insights Employee – HR Meetings Employee Engagement To have improved workplace ‘Pride at Work’ initiative to culture and addr
Slide 15: Financials
Financials Investor Presentation | Quarter Ended 30 June 2024 14
Slide 16: Financials – Q1 FY25
Financials – Q1 FY25 (Rs. in Crores) Net Sales Profit Before Tax 9.43 Profit After Tax 83.74 77.86 6.35 7.01 4.62 Q1 FY25 Q1 FY24 Q1 FY25 Q1 FY24 Q1 FY25 Q1 FY24 Growth: 7.55% Investor Presentation | Quarter Ended 30 June 2024 15
Slide 17: Financials – Q1 FY25
Financials – Q1 FY25 (Rs. in Crores) Net Sales - OTC Net Sales - Beverages 10.96 11.29 72.64 66.15 Q1 FY25 Q1 FY24 Q1 FY25 Q1 FY24 Growth: 9.81% Net Sales - Comfy Net Sales - Electro Plus 26.58 9.44 8.00 19.85 Q1 FY25 Q1 FY24 Q1 FY25 Q1 FY24 Growth: 33.90% Growth: 18.00% Investor Presentation | Quar
Slide 18: Expenses – Q1 FY25
Expenses – Q1 FY25 Employee Benefit Expenses (Rs. in Crores) 13.86 11.37 Q1 FY25 Q1 FY24 Increase: 21.90% Advertisement & Selling Expenses Other Expenses 8.77 13.55 12.18 6.54 Q1 FY25 Q1 FY24 Q1 FY25 Q1 FY24 Increase: 34.10% Increase: 11.25% Investor Presentation | Quarter Ended 30 June 2024 17
Slide 19: Financials – Q1 FY25 – OTC Division
Financials – Q1 FY25 – OTC Division (Rs. in Crores) Net Sales - OTC 72.64 Notes: 66.15 • Majority of raw material prices are lower than last year. Menthol Crystal price is marginally lower than Q1 FY24. Q1 FY25 Q1 FY24 • Majority of packing material prices Growth: 9.81% are lower than Q1 FY24. Net S
Slide 20: Financials – Q1 FY25 – Beverage Division
Financials – Q1 FY25 – Beverage Division (Rs. in Crores) Net Sales - Beverages 10.96 11.29 Notes: • Raw Material prices are higher when compared to Q1 FY24. • Packing Material prices are Q1 FY25 Q1 FY24 marginally higher when compared Q1 FY24. Net Sales - Electro Plus • Advertisement spend is at Rs.
Slide 21: Management Commentary
Management Commentary Investor Presentation | Quarter Ended 30 June 2024 20
Slide 22: Management Commentary
Management Commentary 1. We saw top line growth in q1 in the high single digits owing to muted demand from the pain category 1. It still was a highest revenue done in quarter 1 ever 2. We are projecting 15% top line growth for the year 3. We saw growth driven by Comfy and Electro plus brands and thi
Slide 23: Investor Presentation | Quarter Ended 30 June 2024
Investor Presentation | Quarter Ended 30 June 2024 22
Amrutanjan Health Care — Q1 FY25 Earnings Presentation on 6ix